---
input_text: Predictors of outcomes in hematopoietic cell transplantation for Fanconi
  anemia. Allogeneic hematopoietic cell transplantation (HCT) remains the only cure
  for the hematologic manifestations of Fanconi anemia (FA). We performed retrospective
  predictor analyses for HCT outcomes in FA for pediatric and young adult patients
  transplanted between 2007 and 2020 across three large referral institutions. Eighty-nine
  patients, 70 with bone marrow failure +/- cytogenetic abnormalities, 19 with MDS/AML,
  were included. Five-year overall survival (OS) was 83.2% and event-free survival
  (EFS) was 74%. Age >=19, HLA mismatch and year of HCT were multivariable predictors
  (MVPs) for OS, EFS and treatment-related mortality (TRM). In the pediatric group,
  TCD was a borderline MVP (P = 0.059) with 5-year OS of 73.0% in TCD vs. 100% for
  T-replete HCT. The cumulative incidence of day 100 grade II-IV aGvHD and 5-year
  cGvHD were 5.6% and 4.6%, respectively. Relapse in the MDS/AML subgroup occurred
  in 4 patients (16%). Graft failure was seen in 9 patients (TCD 6/37 [16%]; T-replete
  3/52 [5.7%]). Six patients developed malignancy after HCT. Survival chances after
  HCT for FA are excellent and associated with high engrafted survival and low toxicity.
  Age >=19, HLA mismatch, year of transplant and 'TCD in the <19 years group' (although
  borderline) were found to be negative predictors for survival.
raw_completion_output: |-
  primary_disease: Fanconi anemia
  medical_actions: Allogeneic hematopoietic cell transplantation (HCT); T-cell depletion (TCD)
  symptoms: bone marrow failure; cytogenetic abnormalities; MDS/AML; graft failure; malignancy after HCT
  chemicals: 
  action_annotation_relationships: Allogeneic hematopoietic cell transplantation (HCT) TREATS bone marrow failure IN Fanconi anemia; Allogeneic hematopoietic cell transplantation (HCT) TREATS cytogenetic abnormalities IN Fanconi anemia; Allogeneic hematopoietic cell transplantation (HCT) TREATS MDS/AML IN Fanconi anemia; T-cell depletion (TCD) PREVENTS graft failure IN Fanconi anemia; Allogeneic hematopoietic cell transplantation (HCT) TREATS malignancy after HCT IN Fanconi anemia
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Allogeneic hematopoietic cell transplantation (HCT) TREATS malignancy after HCT IN Fanconi anemia

  ===

extracted_object:
  primary_disease: MONDO:0019391
  medical_actions:
    - MAXO:0000149
    - T-cell depletion (TCD)
  symptoms:
    - HP:0005528
    - cytogenetic abnormalities
    - MDS/AML
    - graft failure
    - malignancy after HCT
  action_annotation_relationships:
    - subject: Allogeneic hematopoietic cell transplantation
      predicate: TREATS
      object: HP:0005528
      qualifier: MONDO:0019391
      subject_extension: Allogeneic hematopoietic cell transplantation (HCT)
    - subject: MAXO:0000149
      predicate: TREATS
      object: cytogenetic abnormalities
      qualifier: MONDO:0019391
    - subject: <Allogeneic hematopoietic cell transplantation>
      predicate: <TREATS>
      object: <MDS/AML>
      qualifier: <Fanconi anemia>
      subject_extension: <Allogeneic hematopoietic cell transplantation>
    - subject: T-cell depletion
      predicate: PREVENTS
      object: graft failure
      qualifier: MONDO:0019391
      subject_extension: T-cell depletion
    - subject: <Allogeneic hematopoietic cell transplantation>
      predicate: <TREATS>
      object: <malignancy after HCT>
      qualifier: <Fanconi anemia>
      subject_qualifier: <NA>
      object_qualifier: <NA>
      subject_extension: <NA>
      object_extension: <NA>
named_entities:
  - id: MONDO:0019391
    label: Fanconi anemia
  - id: MAXO:0000747
    label: Hematopoietic stem cell transplantation (HSCT)
  - id: CHEBI:18198
    label: ADCs
  - id: CHEBI:4027
    label: cyclophosphamide
  - id: MAXO:0000750
    label: conditioning regimens
  - id: CHEBI:37153
    label: Calcineurin inhibitor
  - id: CHEBI:38215
    label: Calcium channel blocker
  - id: CHEBI:4031
    label: Cyclosporine
  - id: CHEBI:8069
    label: Phenobarbital
  - id: CHEBI:2668
    label: Amlodipine
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: MAXO:0000016
    label: Cellular therapy
  - id: HP:0001871
    label: Blood dyscrasias
  - id: MAXO:0000595
    label: Radiography
  - id: HP:0005528
    label: Bone marrow failure
  - id: HP:0034057
    label: Congenital defects
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:44185
    label: Methotrexate
  - id: MONDO:0005233
    label: Non-small cell lung cancer (NSCLC)
  - id: CHEBI:33364
    label: Platinum
  - id: MAXO:0000647
    label: chemotherapy
  - id: HP:0030358
    label: Non-small cell lung cancer
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation (allo-HSCT)
  - id: HP:0002863
    label: Myelodysplasia
  - id: HP:0001909
    label: Leukemia
  - id: MONDO:0016624
    label: Hereditary anemia
  - id: MAXO:0001001
    label: Gene therapy
  - id: MONDO:0005570
    label: Hematological disorders
  - id: HP:0002664
    label: cancer
  - id: MONDO:0015253
    label: Diamond Blackfan anemia
  - id: MAXO:0000600
    label: Kidney replacement therapy (KRT)
  - id: HP:0000093
    label: Proteinuria
  - id: HP:0003259
    label: Elevated serum creatinine (SCr > 100micromol/l)
  - id: MONDO:0001529
    label: Bone marrow failure (BMF)
  - id: HP:0002860
    label: oral squamous cell carcinoma (SCC)
  - id: MONDO:0100339
    label: Fanconi anemia (FA)
  - id: CHEBI:28680
    label: Ara-C
  - id: CHEBI:27899
    label: Cisplatin
  - id: HP:0011793
    label: Malignant tumors
  - id: HP:0000818
    label: Endocrinopathies
  - id: HP:0002745
    label: Oral leukoplakia
  - id: CHEBI:64357
    label: rituximab
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0002910
    label: elevated liver function tests
  - id: CHEBI:125354
    label: plerixafor
  - id: CHEBI:231614
    label: Nivolumab
  - id: CHEBI:25016
    label: PBS
  - id: MONDO:0009693
    label: Multiple Myeloma
  - id: CHEBI:28876
    label: Melphalan
  - id: CHEBI:229764
    label: Selinexor
  - id: CHEBI:229762
    label: Eltanexor
  - id: HP:0006775
    label: Multiple Myeloma
  - id: CHEBI:229763
    label: exportin 1 inhibitors
  - id: MONDO:0015909
    label: aplastic anemia
  - id: HP:0004808
    label: Acute myeloid leukaemia
  - id: MAXO:0000004
    label: Surgery
  - id: MAXO:0000014
    label: Radiotherapy
  - id: MONDO:0001881
    label: Septic shock
  - id: MAXO:0001021
    label: Antimicrobial treatment
  - id: MAXO:0000174
    label: Antifungal treatment
  - id: HP:0001876
    label: Pancytopenia
  - id: HP:0001945
    label: Fever
  - id: CHEBI:133748
    label: Citrate
  - id: CHEBI:41879
    label: Dexamethasone
  - id: CHEBI:33281
    label: Antimicrobial
  - id: CHEBI:35718
    label: Antifungal
  - id: MONDO:0044033
    label: Posterior reversible encephalopathy syndrome (PRES)
  - id: MAXO:0010030
    label: Bone marrow transplantation
  - id: MAXO:0001188
    label: Laparoscopy
  - id: HP:0000988
    label: Skin rash
  - id: MONDO:0010161
    label: Tyrosinemia Type 1
  - id: HP:0001919
    label: acute kidney injury (AKI)
  - id: HP:0000822
    label: hypertension
  - id: MAXO:0001298
    label: therapy
  - id: HP:0040012
    label: Increased chromosomal breakage
  - id: MONDO:0004631
    label: Tongue cancer (TC)
  - id: CHEBI:4735
    label: EDTA
  - id: HP:0002014
    label: Diarrhea
  - id: HP:0025085
    label: Blood in stool
  - id: HP:0000568
    label: Microphthalmia
  - id: HP:0000482
    label: microcornea
  - id: HP:0000508
    label: ptosis
  - id: HP:0011496
    label: limbal neovascularization
  - id: HP:0001097
    label: keratoconjunctivitis sicca
  - id: CHEBI:62932
    label: Mycophenolate
  - id: MONDO:0008903
    label: Lung Cancer
  - id: MONDO:0100096
    label: COVID-19
  - id: HP:0032169
    label: severe infections
